Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

NSE IPO Fully Subscribed on Day 2; $2.4B India Offering Values Exchange at 42.9x Earnings, Second-Largest After Hyundai Motor India

by Team Lumida
September 18, 2026
in Equities
Reading Time: 4 mins read
A A
0
NSE IPO Fully Subscribed on Day 2; $2.4B India Offering Values Exchange at 42.9x Earnings, Second-Largest After Hyundai Motor India
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • National Stock Exchange of India’s $2.4 billion IPO was fully subscribed on the second day of bidding, bringing world’s busiest derivatives exchange closer to completing one of India’s largest listings. Bids exceeded 88.6 million shares on offer; institutional and wealthy investor portions each covered 1.3 times; retail investors bid for nearly 65% of shares allocated to them. Full subscription on day 2 validates strong investor demand for exchange equity. Bidding scheduled to close Sept. 21. IPO priced at 1,700-1,785 rupees per share; at top end, offering raises 226 billion rupees ($2.4B)—India’s second-largest IPO after Hyundai Motor India’s 279 billion rupees in 2024.
  • NSE valued at 42.9x earnings (for year ended March), representing discount to domestic rival BSE but premium to world’s largest listed exchanges (24-25x earnings multiple). Offering consists entirely of stock sold by existing shareholders. IPO culminates long path dating to 2016 when NSE first filed; delayed for years due to regulatory and governance issues. Anchor investors committed 67.46 billion rupees, including global funds (Goldman Sachs, HSBC, Fidelity, Eastspring) and sovereign wealth funds (GIC Singapore, Abu Dhabi Investment Authority). Domestic anchor investors: Life Insurance Corp., SBI Funds Management, ICICI Prudential Asset Management.
  • Key risk: tighter regulatory scrutiny of speculative derivatives trading, central to NSE profitability. Options trading accounted for ~60% of operating revenue in year ended March, leaving NSE exposed to regulatory measures curbing segment activity. Near-term catalyst: resolution of issues around new closing auction mechanism could provide additional support. Portfolio manager Thomas J. Priju (Karma Capital) sees NSE as “company that shows steady growth over the long term and could become meaningful holding in investors’ portfolios.”
  • NSE’s strength: world’s busiest derivatives exchange by volume; 60% of revenue from options trading (high-margin business); steady growth trajectory; anchor investor quality (Goldman, HSBC, sovereign funds validate institutional confidence). Weakness: regulatory risk around derivatives trading; exposure to speculative activity slowdowns; valuation premium to global exchanges despite India’s growth narrative. Success depends on options trading demand persistence and regulatory environment stability.

What Happened?

National Stock Exchange of India’s $2.4 billion IPO was fully subscribed on day 2 of bidding; bidding scheduled to close Sept. 21. IPO priced at 1,700-1,785 rupees per share; bids exceeded 88.6 million shares on offer. Institutional and wealthy investor portions each covered 1.3 times; retail investors bid for 65% of allocated shares. At top end, offering raises 226 billion rupees ($2.4B)—India’s second-largest IPO after Hyundai Motor India (2024). NSE valued at 42.9x earnings (year ended March), discount to BSE but premium to global exchanges (24-25x). Anchor investors committed 67.46 billion rupees: Goldman Sachs, HSBC, Fidelity, Eastspring, GIC Singapore, Abu Dhabi Investment Authority, Life Insurance Corp., SBI Funds Management, ICICI Prudential Asset Management.

Why It Matters?

For NSE shareholders, full subscription validates demand for derivatives exchange equity; 42.9x earnings valuation premium to global exchanges reflects India growth narrative and derivatives boom. For Indian investors, NSE IPO provides direct exposure to world’s busiest derivatives exchange; options trading (60% of revenue) offers leverage to retail investor participation growth. For Goldman Sachs, HSBC, and international anchor investors, NSE stake provides exposure to Indian market structure and derivatives growth. For domestic anchor investors (LICI, SBI, ICICI), NSE stake strengthens asset management/banking ecosystem exposure. For global exchange operators, NSE’s valuation premium vs. established exchanges (CME, ICE) signals strong growth premium for emerging market exchange platforms.

What’s Next?

Monitor NSE IPO closing Sept. 21; if subscription ratios remain elevated through final day, it would validate strong institutional demand. Track NSE’s listing price vs IPO range; if IPO prices at top end (1,785 rupees), it would signal demand strength. Watch for regulatory announcements post-IPO on derivatives trading scrutiny; if regulator signals curbs on options trading, it could pressure NSE’s valuation. Monitor NSE’s closing auction mechanism resolution; if issue resolves positively, it could provide post-IPO catalyst. Track Hyundai Motor India’s stock performance since 2024 IPO; if HYMOTORS has outperformed, it would validate Indian IPO strength thesis and support NSE’s long-term trajectory. Also watch for options trading volumes post-IPO; if derivatives activity accelerates, it would validate revenue growth thesis and justify 42.9x earnings valuation.

Affected Tickers & Coins: NSE, HYMOTORS, BSE, GS, HSBC, LICI, SBI, ICICIBANK

Source: Bloomberg

Previous Post

Tech Stocks Lead Market Recovery; BOJ Split Vote Weakens Yen 1.3%, Brent Crude Falls Below $104, Anthropic Discloses 25%+ AI R&D Driven by Claude

Recommended For You

Wall Street Trading Boom Loses Steam; BofA Guides Q3 ‘Flat,’ JPMorgan ‘High Teens’ Growth After Q2 Record-Breaking Equities Run

by Team Lumida
15 minutes ago
Wall Street Trading Boom Loses Steam; BofA Guides Q3 ‘Flat,’ JPMorgan ‘High Teens’ Growth After Q2 Record-Breaking Equities Run

Bank of America CEO Moynihan warns Q3 trading flat; JPMorgan guides high teens growth; Goldman says FICC softer; Q2 saw 72% YoY equity trading surge fueled by AI...

Read more

Lucid Partners With Bolt for 25,000 European Robotaxis by 2028; Validates Uber’s $2B Investment as Struggling EV Maker Pursues Profitability

by Team Lumida
16 minutes ago
Lucid Partners With Bolt for 25,000 European Robotaxis by 2028; Validates Uber’s $2B Investment as Struggling EV Maker Pursues Profitability

Lucid and Bolt sign MOU for most ambitious European robotaxi rollout; Lucid targets 2028 launch; CEO Napoli calls deal 'important step' for stabilizing finances.

Read more

Mark Walter’s Money: Investigative Probe Into Cash Flows Between Guggenheim Investments and Walter-Controlled Insurers; KPMG Warnings, Prosecutor Scrutiny

by Team Lumida
19 minutes ago
Mark Walter’s Money: Investigative Probe Into Cash Flows Between Guggenheim Investments and Walter-Controlled Insurers; KPMG Warnings, Prosecutor Scrutiny

$200M+ in booked revenues at Guggenheim awaiting payment from Walter-controlled entities; KPMG auditor flagged revenue recognition concerns; prosecutors investigating insurance misclassifications.

Read more

Three New ETFs Target Tax Deferral, Next-Generation AI Winners and Hedged Bitcoin Exposure

by Team Lumida
16 hours ago
Three New ETFs Target Tax Deferral, Next-Generation AI Winners and Hedged Bitcoin Exposure

Bloomberg Trillions reviews three recent ETF launches covering tax-deferred structures, an AI index beyond the megacaps, and a hedged bitcoin product.

Read more

Novo Nordisk Partners With Orbis for Oral Biologic Pills Worth $1.4B; Eli Lilly Also Stakeholder in AI Drug Design Startup

by Team Lumida
22 hours ago
Novo Nordisk Partners With Orbis for Oral Biologic Pills Worth $1.4B; Eli Lilly Also Stakeholder in AI Drug Design Startup

Novo invests in Orbis to develop oral versions of Ozempic/Wegovy; Orbis uses AI for compound design; Eli Lilly competing as stakeholder.

Read more

Holtec Suspends $900M IPO as ‘Perfect Storm’ Hits AI Data Centre Sector; Nuclear Power Demand Visibility Collapses

by Team Lumida
1 day ago
Rumble Shares Jump as Report Reveals Anthropic as the $13.7 Billion Customer Behind Its August Cloud Deal

Holtec founder Singh cites market sentiment against data centers as reason for IPO withdrawal; nuclear sector aiming to raise billions for AI power infrastructure.

Read more

Reform UK Treasurer Nick Candy Meets Sanctioned Nicaraguan Officials; Metals Exploration Wins 60K-Hectare Mining Rights Days Later

by Team Lumida
1 day ago
Reform UK Treasurer Nick Candy Meets Sanctioned Nicaraguan Officials; Metals Exploration Wins 60K-Hectare Mining Rights Days Later

Metals Exploration awarded 8 concessions adjacent to La India gold mine days after Candy met Laureano Ortega, mining minister, attorney-general; company share price +25% YTD.

Read more

Ion Platform Owner Cuts 20%+ Staff as $11B Debt Burden Buckles Under Rate Hikes and AI Threats to Software Business

by Team Lumida
1 day ago
Ion Platform Owner Cuts 20%+ Staff as $11B Debt Burden Buckles Under Rate Hikes and AI Threats to Software Business

Andrea Pignataro's Mergermarket/Dealogic owner slashing headcount to 4,500 from 6,000; financing costs doubled to $800M/year; bond prices crashed 26% on AI fears.

Read more

DOJ Backs $1.9B Bond Requirement for States Challenging Paramount-Warner Bros Merger; Trial Set for March 2027

by Team Lumida
2 days ago
DOJ Backs $1.9B Bond Requirement for States Challenging Paramount-Warner Bros Merger; Trial Set for March 2027

DOJ urges judge to require states, Writers Guild to post bond; Paramount paying $7M daily fees as deal closure delayed; DOJ-state antitrust enforcement rift widens.

Read more

Walmart Partners With Scan Health Plan to Sell Medicare Advantage Coverage; Costco Also Enters Healthcare Market With Co-Branded Plans

by Team Lumida
2 days ago
Walmart Expands Logistics Services Beyond Its Marketplace: What This Means for Investors

Retailers deploy shopper data and pricing power to enter Medicare Advantage; Walmart and Costco co-brand plans as insurers retreat amid rising medical care costs.

Read more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Elon Musk Reignites Legal Battle Against OpenAI and Sam Altman

Elon Musk Wanted Tesla to Take Over OpenAI, Romantic Partner Testifies in Court

May 7, 2026
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Crypto Winter Forces Bitcoin Miners Into an AI Pivot as Profitability Collapses

December 11, 2025
Goldman’s Big Bet on Wealth Lending: Doubling Down on the Ultra-Rich

Goldman Sachs Slashes US Recession Odds: What Investors Need to Know

August 5, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018